These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16651206)

  • 1. Testosterone therapy in hypogonadal men. Introduction.
    Kaminetsky JC
    Clin Cornerstone; 2005; 7 Suppl 4():S5-7. PubMed ID: 16651206
    [No Abstract]   [Full Text] [Related]  

  • 2. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
    Blick G
    Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IPASS: a study on the tolerability and effectiveness of injectable testosterone undecanoate for the treatment of male hypogonadism in a worldwide sample of 1,438 men.
    Zitzmann M; Mattern A; Hanisch J; Gooren L; Jones H; Maggi M
    J Sex Med; 2013 Feb; 10(2):579-88. PubMed ID: 22812645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of long-term treatment with testosterone on weight and waist size in 411 hypogonadal men with obesity classes I-III: observational data from two registry studies.
    Saad F; Yassin A; Doros G; Haider A
    Int J Obes (Lond); 2016 Jan; 40(1):162-70. PubMed ID: 26219417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of late-onset hypogonadism (andropause) treatment using three different formulations of injectable testosterone.
    Hohl A; Marques MO; Coral MH; Walz R
    Arq Bras Endocrinol Metabol; 2009 Nov; 53(8):989-95. PubMed ID: 20126852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testosterone supplementation versus clomiphene citrate for hypogonadism: an age matched comparison of satisfaction and efficacy.
    Ramasamy R; Scovell JM; Kovac JR; Lipshultz LI
    J Urol; 2014 Sep; 192(3):875-9. PubMed ID: 24657837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical use of androgens.
    Snyder PJ
    Annu Rev Med; 1984; 35():207-17. PubMed ID: 6372655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testosterone supplementation in hypogonadal men: our personal experience.
    Giuberti A; Picozzi SC; Mazza L; Casu M; Viganò P; Manganini V; Strada GR
    Arch Ital Urol Androl; 2005 Dec; 77(4):191-3. PubMed ID: 16444930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life.
    Malkin CJ; Pugh PJ; Morris PD; Kerry KE; Jones RD; Jones TH; Channer KS
    Heart; 2004 Aug; 90(8):871-6. PubMed ID: 15253956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical review 34: Androgen treatment of hypogonadal men.
    Bhasin S
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1221-5. PubMed ID: 1592862
    [No Abstract]   [Full Text] [Related]  

  • 11. Current topics in testosterone replacement of hypogonadal men.
    Nieschlag E
    Best Pract Res Clin Endocrinol Metab; 2015 Jan; 29(1):77-90. PubMed ID: 25617174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleep disturbance as a clinical sign for severe hypogonadism: efficacy of testosterone replacement therapy on sleep disturbance among hypogonadal men without obstructive sleep apnea.
    Shigehara K; Konaka H; Sugimoto K; Nohara T; Izumi K; Kadono Y; Namiki M; Mizokami A
    Aging Male; 2018 Jun; 21(2):99-105. PubMed ID: 28920756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone administration in older men.
    Matsumoto AM
    Endocrinol Metab Clin North Am; 2013 Jun; 42(2):271-86. PubMed ID: 23702401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-reactive protein levels and ageing male symptoms in hypogonadal men treated with testosterone supplementation.
    Giltay EJ; Haider A; Saad F; Gooren LJ
    Andrologia; 2008 Dec; 40(6):398-400. PubMed ID: 19032692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone replacement therapy: Dilemmas and challenges in China and Asia.
    An Q; Gu YQ
    Asian J Androl; 2018; 20(2):149-151. PubMed ID: 29405166
    [No Abstract]   [Full Text] [Related]  

  • 16. Incidence of prostate cancer in hypogonadal men receiving testosterone therapy: observations from 5-year median followup of 3 registries.
    Haider A; Zitzmann M; Doros G; Isbarn H; Hammerer P; Yassin A
    J Urol; 2015 Jan; 193(1):80-6. PubMed ID: 24980615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canadian Society for the Study of the Aging Male: response to health Canada's position paper on testosterone treatment.
    Bain J; Brock G; Kuzmarov I; For The International Consulting Group
    J Sex Med; 2007 May; 4(3):558-566. PubMed ID: 17498097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen replacement in men with hypogonadism and erectile dysfunction.
    Albrecht-Betancourt M; Hijazi RA; Cunningham GR
    Endocrine; 2004; 23(2-3):143-8. PubMed ID: 15146093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypogonadism and cardiovascular diseases in men].
    Ter Arkh; 2011; 83(10):61-7. PubMed ID: 22185029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hormone replacement therapy in men: practical aspects].
    Gamidov SI; Shcherbakov DV; Tazhetdinov OKh; Pavlovichev AA; Iremashvili VV
    Urologiia; 2011; (4):68, 70-3. PubMed ID: 22066247
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.